Consensus Lepu Biopharma Co., Ltd.

Equities

2157

CNE100004SM4

Market Closed - Hong Kong S.E. Other stock markets 01:38:22 10/05/2024 pm IST			5-day change	1st Jan Change
5.83 ^HKD	+6.19%		-5.82%	+38.48%

12/04	Keymed Biosciences Advances Solid Tumors Drug With First Patient Study	MT
27/03	Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on Lepu Biopharma Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

af4740692c0e8178aefff.1BRLD38K7nDYe1PmlAYj30usqXHlYLVxWKDOgAXSEvE.vnEfYh1Opka3HzGL5HwRtgjC_UCJVM0gGer75jKiP6iDXDsiM2HdBrUaIA~e8bc8c4e5e92ae46407a4aadd834978e

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

5.391 CNY

Average target price

4.613 CNY

Spread / Average Target

-14.43%

High Price Target

4.613 CNY

Spread / Highest target

-14.43%

Low Price Target

4.613 CNY

Spread / Lowest Target

-14.43%

Consensus detail

Consensus revision (last 18 months)

Ratings for Lepu Biopharma Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Chiffre d''affaires - Rate of surprise

Company calendar